Free Trial

More on the WH "event" re: Gilead drug details...>

US
US: More on the WH "event" re: Gilead drug details mentioned earlier. Apparently
moved up as press pool was " ushered into Oval Office at 11:41 a.m., where POTUS
was meeting with Louisiana Gov. Edwards," according to WH spokesmen, also
present: Drs. Fauci and Birx, VP Pence, economic adviser Kevin Hassett, and Dr.
Blythe Adamson, senior quantitative scientist at Flatiron Health. Asked about
Gilead Sciences has been reporting positive results for its Remdesivir, Trump
deferred to Fauci. Rough transcript: "So that's something that will go with 31%
improvement, doesn't seem like a knock out, 100%, it is a very important proof
of concept. This is very optimistic, the mortality rate trended towards being
better in the sense of less deaths in the REM designate group. 8% versus 11% in
the placebo group. So bottom line. You're going to hear more details about this
this will be submitted to a peer reviewed journal, and will be peer reviewed
appropriately. But certainly it's a, it's a positive it's a very positive
event," Trump said in response."

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.